@dansfera: The bi-directional relationship just got an upgrade! Turns out, there’s new FDA guidance suggesting sponsors can *stay* engaged with research communities even after the clinical trial officially concludes. [cite: The premise of the video suggests this] Forget the quick wrap-up—this means continuing the dialogue with groups like Latinos in clinical research, medical societies, focus groups, and patient advisory boards for the long haul. It redefines the scope beyond just what's covered by beneficiary inducement rules. This could cement a new decade of genuine partnership, making sure the patient voice continues to be heard long after the final data point is collected! #ClinicalResearch #FDA #PatientAdvocacy #HealthPolicy #CommunityEngagement